Overview
Müllerian duct anomalies-limb anomalies syndrome (also known as Al-Awadi/Raas-Rothschild syndrome or limb/pelvis-hypoplasia/aplasia syndrome) is an extremely rare genetic disorder characterized by the combination of malformations of the Müllerian duct derivatives (uterus, fallopian tubes, and upper vagina) with limb abnormalities. The condition primarily affects the reproductive system and the skeletal/limb system. Key clinical features include absence or severe underdevelopment of the uterus and other Müllerian structures in affected females, along with limb defects that can range from split hand/foot malformations to severe limb reduction defects including absence of long bones (phocomelia or amelia). Pelvic abnormalities, including hypoplasia or aplasia of the pelvis, may also be present. Some cases have been reported with additional features such as renal anomalies and craniofacial findings. The syndrome has been described in a small number of families in the medical literature, and cases have been associated with mutations in the WNT7A gene or the LRP4 gene in some reports, though genetic heterogeneity exists. The condition follows an autosomal recessive inheritance pattern, meaning both parents must carry a copy of the altered gene for a child to be affected. Diagnosis is typically made at birth or prenatally based on the characteristic combination of limb and genital anomalies, often confirmed through imaging studies and genetic testing. There is currently no cure for this syndrome. Treatment is supportive and symptomatic, focusing on orthopedic management of limb defects (including prosthetics and surgical interventions as needed), management of reproductive anomalies, and addressing any associated renal or other organ involvement. A multidisciplinary team including orthopedic surgeons, gynecologists, geneticists, and rehabilitation specialists is typically involved in the care of affected individuals.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Müllerian duct anomalies-limb anomalies syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Müllerian duct anomalies-limb anomalies syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Müllerian duct anomalies-limb anomalies syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Müllerian duct anomalies-limb anomalies syndrome.
Community
No community posts yet. Be the first to share your experience with Müllerian duct anomalies-limb anomalies syndrome.
Start the conversation →Latest news about Müllerian duct anomalies-limb anomalies syndrome
No recent news articles for Müllerian duct anomalies-limb anomalies syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Müllerian duct anomalies-limb anomalies syndrome
What is Müllerian duct anomalies-limb anomalies syndrome?
Müllerian duct anomalies-limb anomalies syndrome (also known as Al-Awadi/Raas-Rothschild syndrome or limb/pelvis-hypoplasia/aplasia syndrome) is an extremely rare genetic disorder characterized by the combination of malformations of the Müllerian duct derivatives (uterus, fallopian tubes, and upper vagina) with limb abnormalities. The condition primarily affects the reproductive system and the skeletal/limb system. Key clinical features include absence or severe underdevelopment of the uterus and other Müllerian structures in affected females, along with limb defects that can range from split
How is Müllerian duct anomalies-limb anomalies syndrome inherited?
Müllerian duct anomalies-limb anomalies syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Müllerian duct anomalies-limb anomalies syndrome typically begin?
Typical onset of Müllerian duct anomalies-limb anomalies syndrome is neonatal. Age of onset can vary across affected individuals.